These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 115160)

  • 1. Inhibition of hepatic drug-metabolizing enzymes by arachidonic acid.
    Pessayre D; Mazel P; Descatoire V; Rogier E; Feldmann G; Benhamou JP
    Xenobiotica; 1979 May; 9(5):301-10. PubMed ID: 115160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dietary lipid on drug-metabolizing enzymes.
    Wade AE; Norred WP
    Fed Proc; 1976 Nov; 35(13):2475-9. PubMed ID: 824158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of patulin on hepatic monooxygenase in male mice.
    Siraj MY; Hayes AW; Takanaka A; Ho IK
    J Environ Pathol Toxicol; 1980 Sep; 4(2-3):545-53. PubMed ID: 7462918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the oral contraceptive, menstranol, on drug-metabolizing enzymes of female rats in thiamin-supplemented and deficiency states.
    Wade AE; Evans JL; Seitz A
    Pharmacology; 1976; 14(2):104-14. PubMed ID: 822434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE; Evans JS; Holmes D; Baker MT
    Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of certain vitamin deficiencies on hepatic drug metabolism.
    Zannoni VG; Sato PH
    Fed Proc; 1976 Nov; 35(13):2464-9. PubMed ID: 976490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol.
    Rush WR; Smith SA; Mulvey JH; Graham DJ; Chaplin MD
    Drug Metab Dispos; 1987; 15(4):571-8. PubMed ID: 2888633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fate of the new anti-ulcer drug enprostil in animals. 4th communication: effect on hepatic drug metabolizing enzyme system in rats.
    Yamada Y; Nakahara M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1989 Mar; 39(3):356-60. PubMed ID: 2502989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of perinatal low protein diets on the ontogeny of select hepatic cytochrome p450 enzymes and cytochrome p450 reductase in the rat.
    Cherala G; Shapiro BH; D'mello AP
    Drug Metab Dispos; 2007 Jul; 35(7):1057-63. PubMed ID: 17392395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of tolerance to the prolongation of hexobarbitone sleeping time caused by cannabidiol.
    Borys HK; Ingall GB; Karler R
    Br J Pharmacol; 1979 Sep; 67(1):93-101. PubMed ID: 497524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hepatic microsomal cytochrome P-450-dependent monooxygenase reactions by fatty acyl CoA.
    Abbott VS; Mannering GJ
    Mol Pharmacol; 1979 Mar; 15(2):410-8. PubMed ID: 112378
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of desoxycorticosterone on the activity of drug-metabolizing enzyme systems.
    Tantcheva L; Stoytchev T
    Acta Physiol Pharmacol Bulg; 1989; 15(2):33-9. PubMed ID: 2801146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity.
    Goel A; Dani V; Dhawan DK
    Toxicol Lett; 2007 Feb; 169(1):26-33. PubMed ID: 17194553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression of the hepatic cytochrome P-450 monooxygenase system by treatment of mice with the antineoplastic agent 5-azacytidine.
    Gooderham NJ; Mannering GJ
    Cancer Res; 1985 Apr; 45(4):1569-72. PubMed ID: 2579731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dantrolene inhibition of the hepatic mixed function oxidase system.
    Francis KT; Hamrick ME
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):69-80. PubMed ID: 441518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of substrate binding capacity of the hepatic microsomal cytochrome P-450 in Fasciola hepatica infected rats: toxicological implications.
    Maffei Facino R; Carini M
    Farmaco Sci; 1982 Mar; 37(3):184-91. PubMed ID: 6802668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression of the hepatic cytochrome P-450 mono-oxygenase system by administered tilorone (2,7-bis(2-(diethylamino)ethoxy)fluoren-9-one dihydrochloride).
    Renton KW; Mannering GJ
    Drug Metab Dispos; 1976; 4(3):223-31. PubMed ID: 6226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of zinc on NADPH oxidation and monooxygenase activity in rat hepatic microsomes.
    Jeffery EH
    Mol Pharmacol; 1983 Mar; 23(2):467-73. PubMed ID: 6132332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of 1-alkylimidazoles on hepatic drug-metabolizing enzyme activity.
    Palmer ED; Cawthorne MA
    Xenobiotica; 1974 Apr; 4(4):209-17. PubMed ID: 4847029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.